Barillà D - Search Results

1

Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry.

De Rosa FG, Palazzo A, Rosso T, Shbaklo N, Mussa M, Boglione L, Borgogno E, Rossati A, Mornese Pinna S, Scabini S, Chichino G, Borrè S, Del Bono V, Garavelli PL, Barillà D, Cattel F, Di Perri G, Ciccone G, Lupia T, Corcione S. De Rosa FG, et al. Among authors: barilla d. J Clin Med. 2021 May 1;10(9):1951. doi: 10.3390/jcm10091951. J Clin Med. 2021. PMID: 34062864 Free PMC article.

2

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board. Hartman ML, et al. J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23. J Clin Endocrinol Metab. 2013. PMID: 23345098 Free PMC article.

3

Selective effects of thiazide on intestinal absorption of calcium and adsorptive and renal hypercalciurias.

Barilla DE, Tolentino R, Kaplan RA, Pak CY. Barilla DE, et al. Metabolism. 1978 Feb;27(2):125-31. doi: 10.1016/0026-0495(78)90158-0. Metabolism. 1978. PMID: 202838

4

An exaggerated augmentation of renal calcium excretion after oral glucose ingestion in patients with renal hypercalciuria.

Barilla DE, Townsend J, Pak CY. Barilla DE, et al. Invest Urol. 1978 May;15(6):486-8. Invest Urol. 1978. PMID: 348635 Clinical Trial.

5

Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium.

Barilla DE, Notz C, Kennedy D, Pak CY. Barilla DE, et al. Am J Med. 1978 Apr;64(4):579-85. doi: 10.1016/0002-9343(78)90576-4. Am J Med. 1978. PMID: 645724

6

Pitfalls in parathyroid evaluation in patients with calcium urolithiasis.

Barilla DE, Pak CY. Barilla DE, et al. Urol Res. 1979 Sep;7(3):177-82. doi: 10.1007/BF00257203. Urol Res. 1979. PMID: 505680

7

Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.

Fetner CD, Barilla DE, Townsend J, Pak CY. Fetner CD, et al. Among authors: barilla de. J Urol. 1978 Oct;120(4):399-401. doi: 10.1016/s0022-5347(17)57198-0. J Urol. 1978. PMID: 702659

8

Effect of phenytoin on bone and vitamin D metabolism.

Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M. Bell RD, et al. Among authors: barilla de. Ann Neurol. 1979 Apr;5(4):374-8. doi: 10.1002/ana.410050411. Ann Neurol. 1979. PMID: 220903

9

Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.

Pak CY, Barilla DE, Holt K, Brinkley L, Tolentino R, Zerwekh JE. Pak CY, et al. Among authors: barilla de. Am J Med. 1978 Oct;65(4):593-9. doi: 10.1016/0002-9343(78)90846-x. Am J Med. 1978. PMID: 707519 No abstract available.

10

Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate.

Pak CY, Waters O, Arnold L, Holt K, Cox C, Barilla D. Pak CY, et al. Among authors: barilla d. J Clin Invest. 1977 Mar;59(3):426-31. doi: 10.1172/JCI108656. J Clin Invest. 1977. PMID: 14173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page